Relay Medical Competitors

Ortho Clinical Diagnostics (NASDAQ:OCDX) and Relay Medical (OTCMKTS:RYMDF) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Earnings and Valuation

This table compares Ortho Clinical Diagnostics and Relay Medical's top-line revenue, earnings per share and valuation.

Profitability

This table compares Ortho Clinical Diagnostics and Relay Medical's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent recommendations for Ortho Clinical Diagnostics and Relay Medical, as provided by MarketBeat.com.

Ortho Clinical Diagnostics currently has a consensus price target of $24.5455, indicating a potential upside of 15.94%. Given Ortho Clinical Diagnostics' higher possible upside, research analysts plainly believe Ortho Clinical Diagnostics is more favorable than Relay Medical.

Summary

Ortho Clinical Diagnostics beats Relay Medical on 2 of the 2 factors compared between the two stocks.

Olink Holding AB (publ) (NASDAQ:OLK) and Relay Medical (OTCMKTS:RYMDF) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.

Earnings & Valuation

This table compares Olink Holding AB (publ) and Relay Medical's revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a summary of current recommendations for Olink Holding AB (publ) and Relay Medical, as provided by MarketBeat.com.

Olink Holding AB (publ) presently has a consensus target price of $44.00, suggesting a potential upside of 64.61%. Given Olink Holding AB (publ)'s higher probable upside, equities research analysts clearly believe Olink Holding AB (publ) is more favorable than Relay Medical.

Profitability

This table compares Olink Holding AB (publ) and Relay Medical's net margins, return on equity and return on assets.

Summary

Olink Holding AB (publ) beats Relay Medical on 2 of the 2 factors compared between the two stocks.

Relay Medical (OTCMKTS:RYMDF) and Inotiv (NASDAQ:NOTV) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, profitability and analyst recommendations.

Profitability

This table compares Relay Medical and Inotiv's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Relay Medical and Inotiv's revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Relay Medical and Inotiv, as provided by MarketBeat.

Biodesix (NASDAQ:BDSX) and Relay Medical (OTCMKTS:RYMDF) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

Analyst Ratings

This is a summary of recent recommendations and price targets for Biodesix and Relay Medical, as reported by MarketBeat.com.

Biodesix currently has a consensus price target of $26.00, indicating a potential upside of 73.22%. Given Biodesix's higher possible upside, equities research analysts plainly believe Biodesix is more favorable than Relay Medical.

Valuation & Earnings

This table compares Biodesix and Relay Medical's top-line revenue, earnings per share (EPS) and valuation.

Profitability

This table compares Biodesix and Relay Medical's net margins, return on equity and return on assets.

Summary

Biodesix beats Relay Medical on 2 of the 2 factors compared between the two stocks.

Akumin (NASDAQ:AKU) and Relay Medical (OTCMKTS:RYMDF) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, earnings, dividends, profitability and risk.

Profitability

This table compares Akumin and Relay Medical's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Akumin and Relay Medical's gross revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Akumin and Relay Medical, as reported by MarketBeat.com.

Insider and Institutional Ownership

30.4% of Akumin shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Akumin beats Relay Medical on 2 of the 2 factors compared between the two stocks.

Lucira Health (NASDAQ:LHDX) and Relay Medical (OTCMKTS:RYMDF) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation.

Profitability

This table compares Lucira Health and Relay Medical's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Lucira Health and Relay Medical, as provided by MarketBeat.com.

Lucira Health presently has a consensus price target of $9.00, suggesting a potential upside of 97.37%. Given Lucira Health's higher possible upside, research analysts plainly believe Lucira Health is more favorable than Relay Medical.

Earnings and Valuation

This table compares Lucira Health and Relay Medical's revenue, earnings per share and valuation.

Summary

Lucira Health beats Relay Medical on 2 of the 2 factors compared between the two stocks.